news Archives - Page 66 of 100 - Journal for Clinical Studies

Current Edition

news

Seoul tops the list of most clinical trials conducted in a city

Seoul ranks first in the world in number of clinical trials per city. It is meaningful that the city shows a significant gap with Houston of U.S., which took second p...

17 January 2018 news city | clinical trials

Continue Reading →

news

Antibiotic resistance: Pherecydes Pharma raises €8.7M ($10.3M)

Pherecydes Pharma, a biotechnology company specialized in the research and development of anti-infective therapies based on the use of bacteriophages, today announces...

17 January 2018 news antibiotic resistance | bacteriophages

Continue Reading →

news

Heptares and ICL sign gastrointestinal R&D pact

Heptares Therapeutics, the UK-headquartered wholly-owned subsidiary of Japan’s Sosei Group, has formed a new drug research and development pact with Imperial College ...

17 January 2018 news gastrointestinal | immune disorder

Continue Reading →

news

MyDx’s Biopharmaceutical Division Commences Clinical Trials On Its Unique MyDx360 Pain Management Formula

MyDx, Inc. (OTCQB: MYDX), a science and technology company and creator of MyDx® (My Diagnostic), the first multi-use handheld chemical analyzer designed for Cannabis ...

17 January 2018 news cannabis | management

Continue Reading →

news

Eurocine Vaccines Obtains Authorization to Conduct the Next Study with Immunose™ FLU

Eurocine Vaccines today announced that the company has received authorization to conduct a phase I/II clinical study on the quadrivalent influenza vaccine candidate...

17 January 2018 news antigen | children

Continue Reading →

news

RadioMedix, Areva Med begin phase 1 trial of AlphaMedix to treat neuroendocrine tumours

RadioMedix,a clinical stage biotechnology company, and Areva Med, a nuclear biotech company, have announced the initiation in the United States of phase 1 trial for A...

17 January 2018 news neuroendocrine | tumour

Continue Reading →

news

TiGenix announces publication in Gastroenterology of 52-week results of the Phase III ADMIRE-CD trial of Cx601

TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company focused on exploiting the anti-inflammatory properties of allogeneic, or donor-d...

17 January 2018 news Crohn's disease | gastroenterology

Continue Reading →

news

AEGLE Platform Demonstrations: Big Data analytics in Healthcare

In February 20th and 22nd and March 15th, Aegle is launching a series of webinars with the objective of demonstrating how the final prototype of the AEGLE platform su...

17 January 2018 news analytics | clinical research

Continue Reading →

news

BerGenBio Meets First Efficacy Endpoint in Phase II Trial With Selective AXL Inhibitor BGB324 (bemcentinib) in NSCLC

BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective Axl kinase inhibitors as a potential cornerstone of combination ca...

10 January 2018 news cancer | combination therapy

Continue Reading →

news

ReCor Medical Announces Completion of RADIANCE-HTN SOLO Hypertension Study

ReCor Medical announced today randomization of its 146th, and final, subject in the SOLO cohort of its RADIANCE-HTN study. RADIANCE-HTN, ReCor's study of its Parad...

10 January 2018 news cohort | completion

Continue Reading →